Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and ...

The human vascular system, a complex network of blood vessels, plays an essential role in maintaining health. Understanding the molecular mechanisms underlying vascular development is important for ...

Researchers from the Paris Brain Institute and Sainte-Justine University Hospital in Montreal have, for the first time, ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...

Vascular Closure Systems, Inc. is pleased to announce that it has recently secured initial corporate funding. The proceeds from the funding will be used to accelerate the development of the company's ...

WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Bryan A. Claseman and Marc Penna have ...

Researchers at China Agricultural University have developed an ovarian follicle-based angiogenesis microphysiological system, or OF-AMPS, for rapid and quantitative screening of anti-angiogenic ...